Ë¿¹ÏÊÓƵ

Medical device regulatory laws continue to evolve not only with European Union changes to the Ë¿¹ÏÊÓƵ Regulation, but also with global harmonization efforts across the U.S. Food and Drug...

Susan Schniepp and Andrew Harrison discuss the requirements for a successful corrective action and preventive action (CAPA) system. Q. I work for a contract manufacturing organization (CMO) and am responsible...

Lisa Michels, General Counsel and regulatory affairs expert at Ë¿¹ÏÊÓƵ Compliance Associates® Inc., discusses regulatory strategies for software as a medical device (SaMD), artificial intelligence and other emerging technologies. She...

The MDR Delay’s Impact on Ë¿¹ÏÊÓƵ and Testing—An Orthopedic Innovators Q&A While the recent MDR delay gives companies some breathing room, it should not stall their effort in ensuring their...

Susan J. Schniepp, distinguished fellow at Ë¿¹ÏÊÓƵ Compliance Associates, addresses the difference between regulatory compliance and real compliance. Q: I just attended a meeting where someone talked about the concept...

Organizations don't perform optimally on the fly, so it's important to prepare and practice the inspection strategy in advance, not simply rely on internal audits to ready the organization.